How can we use technology to create a true picture of human health?

Imagine a chemist and an engineer and a doctor and a behavioral scientist, all working together to truly understand health and to better prevent, detect, and manage disease. Picture a world in which technology and life sciences are not distinct, but partners with a united mission.

At Verily, that’s the world we want to create. Our multidisciplinary teams have access to advanced research tools, large scale computing power, and unique technical expertise. We work with partners from across the industry and many fields of research to develop new technology, launch studies, and start companies.

Our mission is to bring together technology and life sciences to uncover new truths about health and disease.


The hardware team at Verily is building devices and tools that are smaller, more powerful, and more convenient than ever before. Smaller devices fit more easily into daily life so they can monitor conditions more consistently and proactively signal when something is amiss.

For example, we are currently partnering to develop a contact lens with an embedded glucose sensor. We hope this smart contact lens will make it easier for people with diabetes to monitor themselves continuously by measuring the glucose in their tears.


Information exists in every aspect of our bodies — from our genes to our sleep patterns. Software engineers, analytics experts, and user experience designers at Verily are developing platforms, products, and algorithms that can analyze complex health information. We strive to identify patterns that could reveal early warning signs, more accurately diagnose disease, or point to a more effective treatment.

Our research program in multiple sclerosis, for example, combines wearable sensors with traditional clinical tests, and uses new lab-based tests designed to gather and analyze biological, physiological, behavioral, and environmental variables. Using machine learning algorithms and computational techniques, our software team is looking for signals that could lead to new knowledge about the disease and why it progresses differently among individuals.


Our clinical team works to surface information and insights that the broader health research community can leverage for years to come. We partner with others — including industry, hospitals, government, academic centers, medical societies, and patient advocacy groups — to apply the latest technology to the study of health and disease.

We also collaborate with our hardware and software teams to help guide the development of Verily products and platforms so that they address the real medical needs of healthcare providers and patients. The Baseline Study is one of these dedicated efforts, a multi-year initiative that aims to identify the traits of a healthy human by closely observing the transition to disease.


Our science team is pursuing research that will help us precisely understand the processes that lead to conditions like cancer, heart disease, and diabetes. We develop automated experimental and computational systems biology platforms and life sciences tools that provide more information about biological function in health and disease than has ever been available.

Our programs also include efforts such as bio-molecular nanotechnology for precision diagnostics and therapeutic delivery. We’re also working on advanced imaging methods for applications ranging from early diagnosis to surgical robotics. Our hope is that these tools will deliver deep insights into biological function that will help transform the prevention, detection, and management of disease.

History & Executive Committee

When Google[x] embarked on a project in 2012 to put computing inside a contact lens — an immensely challenging technical problem with an important application to health — we could not have imagined where it would lead us. As a life sciences team within Google[x], we were able to combine the best of our technology heritage with expertise from across many fields. Now, as an independent company, Verily is focused on using technology to better understand health, as well as prevent, detect, and manage disease.

Andy Conrad, Ph.D.

Chief Executive Officer

Formerly the chief scientific officer of LabCorp, Andy is a cell biologist with a doctorate from UCLA. He has always been passionate about early detection and prevention of disease: Andy co-founded the National Genetics Institute, which developed the first cost-effective test to screen for HIV in blood supply.

Brian Otis, Ph.D.

Chief Technical Officer

Brian’s team focuses on end-to-end innovation ranging from integrated circuits to biocompatible materials to sensors. He joined Google[x] as founder of the smart contact lens project and now leads our efforts across all hardware and device projects, including wearables, implanted devices, and technology like Liftware.

Jessica Mega, M.D., MPH

Chief Medical Officer

Jessica leads the clinical strategy and research team at Verily. She is a board-certified cardiologist who trained and practiced at Massachusetts General Hospital and Brigham and Women’s Hospital. As a faculty member at Harvard Medical School and a senior investigator with the TIMI Study Group, Jessica directed large, international trials evaluating novel cardiovascular therapies.

Linus Upson

Head of Engineering

A long-time Google software engineer, Linus has been a team lead in developing products that now help billions of people worldwide find the information they need on the Internet, including Chrome and Chrome OS. He now oversees our engineering teams.

Tom Stanis

Head of Software

Tom spent nine years working on core Google products before joining Google[x] in 2014 to work on the Baseline Study. He now leads all our Software projects, including the development of machine learning algorithms for applications ranging from robotic-assisted surgery to diabetes management.

Vikram (Vik) Bajaj, Ph.D.

Chief Scientific Officer

Vik's broad research interests in industry and as a former academic principal investigator have included structural and systems biology, molecular imaging, nanoscience, and bioinformatics. Vik now leads the Science team in research directions related to our mission.